Fulmer updated her LinkedIn profile in early September to say that she is now a senior director of health policy at Mayo ...

After two months with a kidney from a gene-edited Yucatan minipig named Lavender, a New Hampshire man is off dialysis. Soon, ...

A positive readout of a Rapport Therapeutics seizure medicine in a mid-stage clinical trial sent company shares soaring, as ...

A renewed focus on children’s health has many asking what can be done to set the next generations up for success. Here’s one ...

Epic Systems will face claims that it illegally used monopoly power as the nation’s dominant electronic health record vendor to unfairly butt out rival Particle Health from a growing business serving ...

Arena BioWorks, the research institute that launched last year with $500 million from a group of high-profile billionaires, ...

Thanks to chatbots, “patients aren’t just arriving with facts. They’re arriving with shaped, rehearsed stories,” writes ...

A Rapport Therapeutics seizure medicine succeeded in a mid-stage clinical trial, sending company shares soaring.

Alkermes and Takeda released data on drug candidates that could fuel the race to develop a new class of therapies and ...

We all benefit from a well-functioning and well-funded NIH. But it needs reform, writes the Good Science Project’s Stuart ...

The FDA is tightening oversight of imports of GLP-1 drug ingredients amid concerns many of the items may be adulterated and pose a safety risk ...

LONDON — A British cardiologist who has touted his connections to top Trump administration health officials has set off a ...